These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27904178)

  • 21. Misuse of topical corticosteroids: A clinical study of adverse effects.
    Dey VK
    Indian Dermatol Online J; 2014 Oct; 5(4):436-40. PubMed ID: 25396124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misuse of Topical Corticosteroids over Face: A Clinical Study.
    Manchanda K; Mohanty S; Rohatgi PC
    Indian Dermatol Online J; 2017; 8(3):186-191. PubMed ID: 28584755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inappropriate Use of Topical Corticosteroides in the Dermatology Outpatient.
    Lovrić I; Tomić I; Tomić I; Zeljko I; Bevanda M; Mandić M; Lovrić S; Šimić D
    Psychiatr Danub; 2021 Sep; 33(Suppl 10):71-75. PubMed ID: 34672275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical steroid abuse: its use as a depigmenting agent.
    Nnoruka E; Okoye O
    J Natl Med Assoc; 2006 Jun; 98(6):934-9. PubMed ID: 16775916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid acne and rebound phenomenon.
    Harlan SL
    J Drugs Dermatol; 2008 Jun; 7(6):547-50. PubMed ID: 18561585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Spectrum of Cutaneous Adverse Drug Reactions Following the Application of Topical Medications: An Observational Study at a Tertiary Care Center.
    Makwana VS; Bhadja SG; Songara BM; Patel ZR; Vyas AP
    Cureus; 2022 Aug; 14(8):e28139. PubMed ID: 36134045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Male genital dermatophytosis - clinical features and the effects of the misuse of topical steroids and steroid combinations - an alarming problem in India.
    Verma SB; Vasani R
    Mycoses; 2016 Oct; 59(10):606-14. PubMed ID: 27028087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of topical steroid phobia in dermatology patients, a cross-sectional study from an urban area of Pakistan.
    Masood S; Jalil P; Awan S; Ghulam U; Kerawala SR
    J Dermatolog Treat; 2022 Jun; 33(4):2331-2334. PubMed ID: 34334088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinicoepidemiological study of topical corticosteroid misuse at a tertiary care center.
    Srivastava A
    J Dermatolog Treat; 2019 Nov; 30(7):685-690. PubMed ID: 30394142
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical corticosteroids usage in dermatology.
    Uppal R; Sharma SC; Bhowmik SR; Sharma PL; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):48-50. PubMed ID: 2026463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical Steroid Damaged Face: A Cross-Sectional Study from Saudi Arabia.
    Al Dhafiri M; Alali AB; Alghanem ZA; Alsaleh ZW; Boushel EA; Alali ZB; Alnajjar AA
    Clin Pract; 2022 Feb; 12(1):140-146. PubMed ID: 35200269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class I topical corticosteroid use by psoriasis patients in an academic practice.
    Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
    Shrestha S; Jha AK; Thapa DP; Bhattarai CK; Ghimire A
    Nepal Med Coll J; 2014 Sep; 16(1):1-4. PubMed ID: 25799800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical steroid-damaged skin.
    Abraham A; Roga G
    Indian J Dermatol; 2014 Sep; 59(5):456-9. PubMed ID: 25284849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
    Lonsdale-Eccles AA; Velangi S
    Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical Steroid Damaged/Dependent Face (TSDF): An Entity of Cutaneous Pharmacodependence.
    Lahiri K; Coondoo A
    Indian J Dermatol; 2016; 61(3):265-72. PubMed ID: 27293246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefit of Preoperative Oral Steroids during Sinus Surgery when Utilizing Concentrated Topical Epinephrine.
    Korkmaz H; Yao W; Korkmaz M; Bleier BS
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(4):216-22. PubMed ID: 27383647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of topical steroid treatment on idiopathic granulomatous mastitis: clinical and radiologic evaluation.
    Gunduz Y; Altintoprak F; Tatli Ayhan L; Kivilcim T; Celebi F
    Breast J; 2014; 20(6):586-91. PubMed ID: 25228089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.